FMI
Factory Mutual Insurance Portfolio holdings
AUM
$9.15B
1-Year Return
21.64%
This Quarter Return
+1.86%
1 Year Return
+21.64%
3 Year Return
+93.02%
5 Year Return
+157.54%
10 Year Return
+334.28%
AUM
$9.25B
AUM Growth
-$421M
(-4.4%)
Cap. Flow
-$466M
Cap. Flow
% of AUM
-5.04%
Top 10 Holdings %
Top 10 Hldgs %
39.93%
Holding
177
New
4
Increased
21
Reduced
40
Closed
5
Top Buys
| 1 |
iShares Core MSCI Total International Stock ETF
IXUS
|
$39.6M |
| 2 |
Intuit
INTU
|
$33.2M |
| 3 |
Tesla
TSLA
|
$15.4M |
| 4 |
Idexx Laboratories
IDXX
|
$13.8M |
| 5 |
NXP Semiconductors
NXPI
|
$12.4M |
Top Sells
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
$92.3M |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
$56.1M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
$55.8M |
| 4 |
Broadcom
AVGO
|
$31.5M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$30.5M |
Sector Composition
| 1 | Technology | 23.53% |
| 2 | Financials | 8.98% |
| 3 | Communication Services | 7.8% |
| 4 | Healthcare | 7.74% |
| 5 | Consumer Discretionary | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares MSCI Australia ETF
EWA
$1.54B
| $11.1M | 0.12% |
465,100
| – | – |
|
152
Micron Technology
MU
$144B
| $11.1M | 0.12% |
131,745
+46,000
| +54% | +$3.87M |
|
153
Starbucks
SBUX
$98.6B
| $11.1M | 0.12% |
121,300
-201,800
| -62% | -$18.4M |
|
154
iShares Biotechnology ETF
IBB
$5.73B
| $9.39M | 0.1% |
71,000
| – | – |
|
155
American International
AIG
$45.1B
| $9.23M | 0.1% |
126,800
| – | – |
|
156
CVS Health
CVS
$93.3B
| $9.03M | 0.1% |
201,243
| – | – |
|
157
O'Reilly Automotive
ORLY
$88.9B
| $8.89M | 0.1% |
112,500
| – | – |
|
158
Advanced Micro Devices
AMD
$251B
| $8.83M | 0.1% |
73,072
| – | – |
|
159
Intuitive Surgical
ISRG
$164B
| $7.99M | 0.09% |
15,300
-5,200
| -25% | -$2.71M |
|
160
Biogen
BIIB
$20.7B
| $7.52M | 0.08% |
49,200
| – | – |
|
161
Delta Air Lines
DAL
$40.2B
| $7.14M | 0.08% |
118,000
| – | – |
|
162
Boston Scientific
BSX
$159B
| $6.35M | 0.07% |
71,100
-85,300
| -55% | -$7.62M |
|
163
IBM
IBM
$232B
| $6.33M | 0.07% |
28,800
| – | – |
|
164
MetLife
MET
$54.6B
| $5.63M | 0.06% |
68,800
| – | – |
|
165
Edwards Lifesciences
EW
$47.7B
| $5.56M | 0.06% |
75,100
| – | – |
|
166
Humana
HUM
$37.6B
| $5.48M | 0.06% |
+21,600
| New | +$5.48M |
|
|
167
iShares MSCI ACWI ex US ETF
ACWX
$6.69B
| $4.69M | 0.05% |
90,000
-1,070,700
| -92% | -$55.8M |
|
168
Regeneron Pharmaceuticals
REGN
$60B
| $2.78M | 0.03% |
+3,900
| New | +$2.78M |
|
169
Vanguard FTSE Emerging Markets ETF
VWO
$97.4B
| $1.24M | 0.01% |
28,100
| – | – |
|
170
Alphabet (Google) Class A
GOOGL
$2.83T
| $947K | 0.01% |
5,000
| – | – |
|
171
Vanguard FTSE All-World ex-US ETF
VEU
$49B
| $689K | 0.01% |
12,000
| – | – |
|
172
Gilead Sciences
GILD
$140B
| $554K | 0.01% |
6,000
| – | – |
|
173
DuPont de Nemours
DD
$32.6B
| – | – |
-257,890
| Closed | -$23M |
|
174
Interactive Brokers
IBKR
$28.1B
| – | – |
-120,000
| Closed | -$4.18M |
|
175
Moderna
MRNA
$9.71B
| – | – |
-41,000
| Closed | -$2.74M |
|